CELLTRION revenue for the last year amounted to 3.56 T KRW, the most of which — 6.07 T KRW — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 1.87 T KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought CELLTRION 1.55 T KRW, and the year before that — 2.11 T KRW.